Latest:
Sentinel Lymph Node Mapping in Endometrial Cancer
Sentinel lymph node mapping shows promise in the management of endometrial cancer, especially if applied using a rigorous staging and treatment algorithm.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Balazs Halmos, MD, MS, Montefiore Einstein Center for Cancer Care
Latest:
Optimizing the Selection of Novel Therapy for Patients With Advanced NSCLC
Closing out their panel on immunotherapy in non–small cell lung cancer, expert oncologists share key takeaways on the selection of novel therapy in this setting.
Barbara Daly, PhD, RN
Latest:
The Benefits for Nurses of Using Psychosocial Cancer Registry Data
Registries, large databases of patient information collected in a systematic, standardized fashion, most often focus on biologic measures, such as pathology, radiology, and laboratory results, to track incidence and prevalence of disease as well as causative factors.
Barbara J. Lennert, RN, BSN, MAOM
Latest:
NOW Initiative: Payer & Provider Collaborations in Oncology Benefits Management
Payers recognize the need to expand benefits management for oncology but struggle to find effective solutions amid the complexity of
available therapies and skepticism from oncologists, who are facing their own set of economic pressures. The National Oncology Working Group (NOW) Initiative is trying to change the sometimes adversarial
relationship between payers and oncologists through a collaborative model.
Barbara Jones
Latest:
Data Support Safety and Benefit of Chemotherapy Before Radical Cystectomy
Preoperative chemotherapy was not a predictor of postoperative complications, nor did it increase the length of hospital stays or surgical complications among patients undergoing radical cystectomy for muscle-invasive bladder cancer.
Barbara L. Jones
Latest:
B-Cell Malignancies: Transforming Expectations and Outcomes
With the arrival and incorporation into clinical practice of immunomodulatory drugs (IMiDs) and proteasome inhibitor therapy, patients with multiple myeloma are achieving deep, durable responses and disease control, and are living longer.
Barbara McAneny, MD
Latest:
Proving That Value-Based Care Is Possible
More than 2 years after the passage of the Medicare Access and CHIP Reauthorization Act of 2015, the progression toward value-based care has challenged oncologists to assume an unprecedented degree of accountability for the well-being and holistic care of their patients.